Dr. Qura Ain | Phamagenetics | Women Researcher Award
University College Dublin | Pakistan
Dr. Qura Tul Ain is a passionate pharmacogenetic researcher and medical doctor with a strong dedication to advancing knowledge in rare diseases, human genetics, and advanced health sciences. She completed her MBBS from the Services Institute of Medical Sciences in Lahore, where she gained extensive clinical exposure through rotations in medicine, surgery, intensive care, gynecology, and ophthalmology, and later pursued an MPhil in Pharmacology with a specialization in molecular genetics at Shifa Tameer-e-Millat University, Islamabad. Her academic training provided her with expertise in genomics, bioinformatics, and molecular pharmacology, with her thesis focusing on the pharmacogenetics of low-dose empagliflozin in patients with heart failure. Professionally, she has served as a demonstrator in pharmacology at Shifa College of Medicine, alongside clinical roles as a medical officer and house physician in both medicine and surgical departments. Her research interests include pharmacogenomics, molecular genetics, and personalized medicine, with a particular focus on identifying genetic markers that predict treatment outcomes in cardiovascular diseases. She is skilled in laboratory techniques such as PCR, RFLP, DNA/RNA extraction, and gel electrophoresis, which support her translational research. Her contributions have been recognized through research fellowships and academic opportunities, reflecting her commitment to bridging genetics and clinical therapeutics. With her strong foundation in medicine, research, and teaching, Dr. Qura Tul Ain is well positioned to make impactful contributions to precision medicine and healthcare innovation.
Profile: ORCID
Featured Publications
Ain, Q. T., Shaheen, A., Ijaz, U., Ahmed, S., Usman, M., Ahmed, M., Ali, M., Azam, F., Khan, A. A., Hasan, A., et al. (2025). Personalized response to empagliflozin in heart failure: Association of BDNF and ATP2A2 variants in a South Asian cohort. Biomedicines, 13(9), 2095.
Ain, Q. T., Irshad, T., Usman, M., Ali, M. H., Ali, S., Naeem, S., Sajjad, L., Irshad, A., Ahmed, M., Ahmed, M. U., et al. (2025). Colchicine as an adjunct therapy postablation for atrial fibrillation: A systematic review and meta-analysis. Cardiology in Review.
Ahmed, M., Zulfiqar, E., Shafiq, A., Shahzad, M., Hashmi, T. M., Raja, H. A. A., Naveed, M. A., Ain, Q. T., Ahmed, F., Wani, S. A., et al. (2025). Chronic kidney disease and ischemic heart disease mortality in the United States: A 25-year review of racial and geographic disparities. Cardiology in Review.
Anjum, I., Nasir, A., Naseer, F., Ibrahim, A., Rehman, B., Bashir, F., & Ain, Q. T. (2025). Exploring the anti-inflammatory effects of phytochemicals in attenuating interstitial cystitis: A literature review. Frontiers in Pharmacology, 16, 1483548.
Ahmed, M., Ahsan, A., Zia, M. S., Ain, Q. T., Khurshid, S., Basit, J., & Ahmad, T. K. F. (2024). Enhancing WHO prescription writing guideline adherence through an educational intervention: A quality improvement study of Azad Jammu and Kashmir. International Journal of Surgery.